Council considers ban on garden bonfires
A west London council is considering creating a byelaw to ban people from having bonfires in their gardens, with the aim of reducing pollution.
The proposal by Hammersmith and Fulham Council would prevent burning household or garden waste outside, but would not apply to barbecues, domestic fire-pits and indoor wood burning, according to the Local Democracy Reporting Service.
According to Public Health England, deaths from particulate air pollution in Hammersmith and Fulham in 2023 were one per cent above the England average.
A new byelaw can take up to six months to establish, requires a public consultation and the outline of the byelaw must also be approved by the Secretary of State.
Particulate pollution (PM) refers to the mixture of solid particles and liquid droplets suspended in the air that can be either naturally occurring or human-made.
The council must carry out studies of the borough's domestic wood burning emissions and an analysis on the impacts of outdoor fires on public health.
Under the Environmental Protection Act 1990, councils must investigate smoke complaints if it is considered a "statutory nuisance" which can lead to an abatement notice requiring it to stop or be reduced.
However, Hammersmith and Fulham Council says this law is "reactive" - it only applies if someone complains and doesn't ban burning outright, hence their proposed byelaw.
"Outdoor fires and wood burning create harmful particulate matter emissions, for which it is considered there is no safe level," a report by the council said.
"Short term exposure to high particulate matter emissions can cause asthma episodes and play a part in a multitude of other longer-term effects."
The byelaw would have "climate adaptation and resilience benefits" reducing the risk of fires becoming "out of control" in warmer and drier weather, the report added.
Listen to the best of BBC Radio London on Sounds and follow BBC London on Facebook, X and Instagram. Send your story ideas to hello.bbclondon@bbc.co.uk
Hammersmith & Fulham Borough Council
Local Democracy Reporting Service
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
E&E News
2 hours ago
- E&E News
Power plant rollback could compel clampdown on other polluters
EPA's newly proposed rollback of stricter power industry air toxics regulations could carry a ricochet effect: states having to toughen controls on other pollution sources to meet required air quality goals, according to an in-house analysis released this week. Under the draft rule published Tuesday, the agency would scrap regulations updated last year primarily to tighten emission limits on mercury, arsenic and other hazardous metals from coal-fired power plants. But as a side benefit, those regulations were also expected to cut concentrations of smog and soot in parts of the United States, possibly including some that were flunking ambient air quality standards for one or both of those pollutants, the regulatory impact analysis says. Advertisement 'As these emissions reductions will not occur under this proposed repeal action, states may need to pursue emissions reductions from other sources to reach the standards, incurring costs for those sources,' the analysis says.
Yahoo
6 hours ago
- Yahoo
Weight loss pill shows promise in new trial
A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.
Bloomberg
6 hours ago
- Bloomberg
UK Heat Wave Could Claim Nearly 600 Lives This Week, Experts Warn
Scientists have warned the elderly and other vulnerable groups in the UK are at risk of heat-related deaths this weekend, as a new study shows recent high temperatures could claim 570 lives in just over four days. Researchers at the London School of Hygiene & Tropical Medicine and Imperial College London published on Saturday a real-time analysis calculating the number of heat-related deaths expected from Thursday to Sunday.
